Cardiovascular health, orthostatic hypotension, and cognitive aging
Author: Xia, Xin
Date: 2023-10-20
Location: Andreas Vesalius, Berzelius väg 3, Karolinska Institutet, Solna
Time: 13:00
Department: Inst för neurobiologi, vårdvetenskap och samhälle / Dept of Neurobiology, Care Sciences and Society
View/ Open:
Thesis_Xin_Xia.pdf (1.427Mb)
Abstract
Cardiovascular health (CVH) plays an important role in dementia development. Ideal CVH, defined by Life’s Simple 7 (LS7), has been associated with a lower risk of dementia in older adults. Orthostatic hypotension (OH) may be a novel cardiovascular risk factor that can affect dementia development. In this thesis, population-based cohort studies were conducted to investigate the role of LS7-defined CVH and OH in cognitive aging in people aged ≥60 years using data from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K).
Study I investigated LS7-defined CVH in relation to transitions between normal cognition, cognitive impairment, no dementia (CIND), and dementia. The study found that people with better CVH had a lower hazard of transitioning directly from normal cognition to CIND (HR = 0.76, 95% CI = 0.61-0.95) and dementia (HR = 0.42, 95% CI = 0.21-0.82) in people aged <78 years. In addition, people aged <78 years with better CVH had two to three more years of life living with normal cognition. However, CVH, defined by LS7, was not related to transitions between cognitive states in people aged ≥78 years.
Study II evaluated the associations between OH and dementia. Of the 2532 people who were initially free of dementia, 615 (24.3%) people had OH. People with OH had higher hazards of developing dementia (HR = 1.40, 95% CI = 1.10–1.76) and Alzheimer’s disease (HR = 1.39, 95% CI = 1.04–1.86). In addition, OH was related to a higher hazard of progression from CIND to dementia in people with CIND (HR = 1.54, 95% CI = 1.05–2.25) but not with incident CIND in those without CIND and dementia (HR = 1.15, 95% CI = 0.94–1.40).
Study III investigated the impact of OH on the development of CVDs and dementia in people initially free of CVDs as well as the impact of OH on dementia development in people with CVDs. The study found that in people who were initially free of CVDs, individuals who had OH at baseline had a higher hazard of developing CVDs (HR = 1.33, 95% CI = 1.12-1.59) but not dementia (HR = 1.22, 95% CI = 0.83-1.81) compared to those without OH. Among those with CVDs, persons with OH also had a higher hazard of dementia (HR = 1.54, 95% CI = 1.06-2.23) compared to those without OH.
Study IV assessed the associations of OH, in the presence or absence of frailty, with dementia and mortality. This study found that individuals who had OH at baseline had a higher hazard of dementia in the presence (HR = 2.73, 95% CI = 1.82-4.10) and absence (HR = 2.28, 95% CI = 1.47-3.54) of frailty than robust persons without OH. However, OH was only associated with a higher hazard of death without dementia when accompanied by frailty (HR = 1.56, 95% CI = 1.25-1.96).
Conclusions. Maintaining ideal CVH may protect against cognitive dysfunction and reduce years of life with cognitive dysfunction in younger old age. OH may be a potential modifiable risk factor for dementia, and the intermediate development of CVDs may help explain the association between OH and dementia.
Study I investigated LS7-defined CVH in relation to transitions between normal cognition, cognitive impairment, no dementia (CIND), and dementia. The study found that people with better CVH had a lower hazard of transitioning directly from normal cognition to CIND (HR = 0.76, 95% CI = 0.61-0.95) and dementia (HR = 0.42, 95% CI = 0.21-0.82) in people aged <78 years. In addition, people aged <78 years with better CVH had two to three more years of life living with normal cognition. However, CVH, defined by LS7, was not related to transitions between cognitive states in people aged ≥78 years.
Study II evaluated the associations between OH and dementia. Of the 2532 people who were initially free of dementia, 615 (24.3%) people had OH. People with OH had higher hazards of developing dementia (HR = 1.40, 95% CI = 1.10–1.76) and Alzheimer’s disease (HR = 1.39, 95% CI = 1.04–1.86). In addition, OH was related to a higher hazard of progression from CIND to dementia in people with CIND (HR = 1.54, 95% CI = 1.05–2.25) but not with incident CIND in those without CIND and dementia (HR = 1.15, 95% CI = 0.94–1.40).
Study III investigated the impact of OH on the development of CVDs and dementia in people initially free of CVDs as well as the impact of OH on dementia development in people with CVDs. The study found that in people who were initially free of CVDs, individuals who had OH at baseline had a higher hazard of developing CVDs (HR = 1.33, 95% CI = 1.12-1.59) but not dementia (HR = 1.22, 95% CI = 0.83-1.81) compared to those without OH. Among those with CVDs, persons with OH also had a higher hazard of dementia (HR = 1.54, 95% CI = 1.06-2.23) compared to those without OH.
Study IV assessed the associations of OH, in the presence or absence of frailty, with dementia and mortality. This study found that individuals who had OH at baseline had a higher hazard of dementia in the presence (HR = 2.73, 95% CI = 1.82-4.10) and absence (HR = 2.28, 95% CI = 1.47-3.54) of frailty than robust persons without OH. However, OH was only associated with a higher hazard of death without dementia when accompanied by frailty (HR = 1.56, 95% CI = 1.25-1.96).
Conclusions. Maintaining ideal CVH may protect against cognitive dysfunction and reduce years of life with cognitive dysfunction in younger old age. OH may be a potential modifiable risk factor for dementia, and the intermediate development of CVDs may help explain the association between OH and dementia.
List of papers:
I. Xia X, Qiu C, Rizzuto D, Grande G, Laukka EJ, Fratiglioni L, Guo J, Vetrano DL. The age-dependent association of Life's Simple 7 with transitions across cognitive states after age 60. J Intern Med. 2023 Aug;294(2):191202.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Xia X, Wang R, Vetrano DL, Grande G, Laukka EJ, Ding M, Fratiglioni L, Qiu C. From Normal Cognition to Cognitive Impairment and Dementia: Impact of Orthostatic Hypotension. Hypertension. 2021 Sep;78(3):769-778.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Xia X, Qiu C, Rizzuto D, Fratiglioni L, Dai L, Laukka EJ, Grande G, Vetrano DL. Role of Orthostatic Hypotension in the Development of Dementia in People With and Without Cardiovascular Disease. Hypertension. 2023 Jul;80(7):1474-1483.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Xia X, Jönsson L, Tazzeo C, Qiu C, Rizzuto D, Laukka EJ, Grande G, Fratiglioni L, Vetrano DL. Associations of orthostatic hypotension and frailty with dementia and mortality in older adults: a population-based cohort study. [Submitted]
I. Xia X, Qiu C, Rizzuto D, Grande G, Laukka EJ, Fratiglioni L, Guo J, Vetrano DL. The age-dependent association of Life's Simple 7 with transitions across cognitive states after age 60. J Intern Med. 2023 Aug;294(2):191202.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Xia X, Wang R, Vetrano DL, Grande G, Laukka EJ, Ding M, Fratiglioni L, Qiu C. From Normal Cognition to Cognitive Impairment and Dementia: Impact of Orthostatic Hypotension. Hypertension. 2021 Sep;78(3):769-778.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Xia X, Qiu C, Rizzuto D, Fratiglioni L, Dai L, Laukka EJ, Grande G, Vetrano DL. Role of Orthostatic Hypotension in the Development of Dementia in People With and Without Cardiovascular Disease. Hypertension. 2023 Jul;80(7):1474-1483.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Xia X, Jönsson L, Tazzeo C, Qiu C, Rizzuto D, Laukka EJ, Grande G, Fratiglioni L, Vetrano DL. Associations of orthostatic hypotension and frailty with dementia and mortality in older adults: a population-based cohort study. [Submitted]
Institution: Karolinska Institutet
Supervisor: Vetrano, Davide
Co-supervisor: Qiu, Chengxuan; Rizzuto, Debora; Laukka, Erika
Issue date: 2023-09-20
Rights:
Publication year: 2023
ISBN: 978-91-8017-079-6
Statistics
Total Visits
Views | |
---|---|
Cardiovascular ... | 306 |
Total Visits Per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
Cardiovascular ... | 30 | 30 | 14 | 18 | 15 | 9 | 6 |
File Visits
Views | |
---|---|
Thesis_Xin_Xia.pdf | 228 |
Top country views
Views | |
---|---|
Sweden | 151 |
United States | 43 |
Germany | 15 |
Austria | 14 |
China | 9 |
Ireland | 6 |
United Kingdom | 5 |
South Korea | 3 |
Russia | 3 |
Canada | 2 |
Top cities views
Views | |
---|---|
Stockholm | 40 |
Huddinge | 24 |
Roth | 8 |
Skövde | 8 |
Dublin | 6 |
Kista | 6 |
Lund | 6 |
Gävle | 5 |
Solna | 5 |
Ashburn | 4 |